Back
ESC Professional Premium Access

Patient knowledge about risk factors, achievement of target values and guideline adherent secondary prevention 12 months after acute myocardial infarction. Results of the prospective GULLIVE-R study.

Session: Treatment of coronary artery disease
Topic: Pharmacotherapy
Speaker: Professor U. Zeymer (Ludwigshafen, DE)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Professor Uwe Zeymer

Klinikum Ludwigshafen, Ludwigshafen (Germany)
18 presentations
3 followers

5 more presentations in this session

Infarct size, inflammatory burden and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry.

Speaker: Doctor A. Sansonetti (Bologna, IT)

Access
Abstract
Slides
Like
Thumbnail

The effect of P2Y12 inhibitor monotherapy according to bleeding risk: a systematic review and meta-analysis

Speaker: Ms E. Woelders (Nijmegen, NL)

Access
Abstract
Slides
Like
Thumbnail

Positive predictive value of the crusade score for bleeding events in patients with acute coronary syndromes on dual antiplatelet therapy with acetylsalicylic acid and clopidogrel

Speaker: Doctor J. Monteiro (Vila Real, PT)

Access
Abstract
Slides
Like
Thumbnail

To pretreat or not no pretreat with dual antiplatelet therapy in non-ST elevation acute coronary syndrome patients: that is the question.

Speaker: Doctor D. Abella Vallina (Burgos, ES)

Access
Abstract
Slides
Like
Thumbnail

Effect of alirocumab added to high-Intensity statin therapy on endothelial function in patients with acute myocardial infarction: A sub-study of the randomized placebo-controlled PACMAN-AMI trial

Speaker: Doctor E. Rexhaj (Bern, CH)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Treatment of coronary artery disease

Speakers: Professor U. Zeymer, Doctor A. Sansonetti, Ms E. Woelders, Doctor J. Monteiro, Doctor D. Abella Vallina...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources